List of Zosyn drug patents

Zosyn is owned by Wyeth Pharms.

Zosyn contains Piperacillin Sodium; Tazobactam Sodium.

Zosyn has a total of 3 drug patents out of which 0 drug patents have expired.

Zosyn was authorised for market use on 22 October, 1993.

Zosyn is available in injectable;injection dosage forms.

Zosyn can be used as method of treating bacterial infections.

The generics of Zosyn are possible to be released after 14 April, 2023.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8133883 WYETH PHARMS Compositions containing piperacillin and tazobactam useful for injection
Apr, 2023

(2 months from now)

US6900184 WYETH PHARMS Compositions containing pipercillin and tazobactam useful for injection
Apr, 2023

(2 months from now)

US7915229 WYETH PHARMS Compositions containing piperacillin and tazobactam useful for injection
Apr, 2023

(2 months from now)

Drugs and Companies using PIPERACILLIN SODIUM; TAZOBACTAM SODIUM ingredient

Market Authorisation Date: 22 October, 1993

Treatment: Method of treating bacterial infections

Dosage: INJECTABLE;INJECTION

How can I launch a generic of ZOSYN before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic